James Pilling
Impact in
-
- Pluripotent Stem Cells Research
- Wnt/β-catenin signaling in development and cancer
- Bone Metabolism and Diseases
Papers in
-
- Wnt/β-catenin signaling in development and cancer 3
- CRISPR and Genetic Engineering 3
- Protein Degradation and Inhibitors 2
- Oncology 4
- Co-authors
- Amy Pointon (2 shared papers)C Archer (2 shared papers)Thierry Dorval (2 shared papers)Christopher E. Pollard (1 shared paper)Yinhai Wang (1 shared paper)Michael L. Sullivan (2 shared papers)Patrick OʼShea (3 shared papers)Edward Ainscow (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)SLAS DISCOVERY (2 papers)Clinical Cancer Research (1 paper)Toxicological Sciences (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- United KingdomSingaporeUnited States
In The Last Decade
James Pilling
14 papers receiving 348 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 215
- Biomaterials 37
- Cell Biology 40
- Oncology 60
- Biophysics 12
Countries citing papers authored by James Pilling
This map shows the geographic impact of James Pilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Pilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Pilling more than expected).
Fields of papers citing papers by James Pilling
This network shows the impact of papers produced by James Pilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Pilling. The network helps show where James Pilling may publish in the future.
Co-authors
The 25 scholars most cited alongside James Pilling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 99 | |
| 2 | 2016 | 56 | |
| 3 | 2010 | 56 | |
| 4 | 2017 | 29 | |
| 5 | 2017 | 24 | |
| 6 | 2013 | 19 | |
| 7 | 2016 | 18 | |
| 8 | 2019 | 16 | |
| 9 | 2008 | 16 | |
| 10 | 2010 | 11 | |
| 11 | 2010 | 8 | |
| 12 | 2020 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2024 | 0 |
About James Pilling
James Pilling is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Surgery, having authored 15 papers that have together received 355 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (3 papers), CRISPR and Genetic Engineering (3 papers), Pancreatic function and diabetes (2 papers), Protein Degradation and Inhibitors (2 papers), Neuroscience and Neural Engineering (2 papers), Microtubule and mitosis dynamics (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Molecular Biology (215 citations), Biomaterials (37 citations), Cell Biology (40 citations), Oncology (60 citations) and Biophysics (12 citations). James Pilling has collaborated with scholars based in United Kingdom, Singapore and United States. Frequent co-authors include Amy Pointon, C Archer, Thierry Dorval, Christopher E. Pollard, Yinhai Wang, Michael L. Sullivan, Patrick OʼShea, Edward Ainscow, Mounira Djerbi and Ilaria Bellantuono. Their work appears in journals such as Molecular Cancer Therapeutics, SLAS DISCOVERY, Clinical Cancer Research, Toxicological Sciences and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.